FindTrial
Sign In

Surgical condition in endoscopic sinus surgery

Effect of the dose of remifentanil on the surgical conditions in endoscopic sinus surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006453
Enrollment
54
Registered
2021-08-17
Start date
2021-06-17
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Guri Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 54 patients undergoing elective surgical procedures who are between American society of anesthesiologists(ASA) classification I and II, and age between 18 and 65.

Exclusion criteria

Exclusion criteria: 1) Patient with allergy to egg or soybean oil, 2) Patient with history of drug abuse, and 3) Patient with underlying medical conditions such as hypertension, diabetes mellitus and under medication

Design outcomes

Primary

MeasureTime frame
systolic blood pressue, diastolic blood pressure, meam arterial pressure, heart rate, Bispectral index, stroke volume and cardiac output—

Secondary

MeasureTime frame
VAS(visual analog scale) score, PONV(postoperative nausea and vomiting) score—

Countries

Korea, Republic of

Contacts

Public ContactSangyun Cho

Hanyang University Guri Hospital

chosy063@hanyang.ac.kr+82-31-560-2400

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 8, 2026